Breast Cancer :: FDA recommends Evista use to reduce breast cancer risk in postmenopausal women

Eli Lilly and Company (NYSE: LLY) announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend approval of its osteoporosis drug EVISTA(R) (raloxifene HCl) for a new use to reduce invasive breast cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer.

BMA :: Doctors under attack says British Medical Association

A call to Gordon Brown to make a new start with doctors, came in the opening speech at the British Medical Association?s (BMA) annual conference. Dr Sam Everington, Acting BMA Chairman, urged the new Prime Minister to avoid future agonies for the NHS ? a health service in which doctors felt under attack.

Healthcare :: Physician Assistants vote on retail clinics, reparative therapy

Physician assistants (Pas) addressed a broad range of issues ? including overcrowding in emergency departments, retail clinics, reparative therapy, retail-based clinics, deceptive health care advertising, and apologizing for adverse outcomes ? during the 35th annual conference of the American Academy of Physician Assistants (AAPA), meeting in Philadelphia through May 31.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack